New Antidepressant Strategy Targets Brain Receptors for Rapid Relief
Scientists develop pathway-selective drug that activates beneficial brain receptors while avoiding negative feedback loops.
446 articles in this topic
Scientists develop pathway-selective drug that activates beneficial brain receptors while avoiding negative feedback loops.
New review examines breakthrough amyloid-targeting immunotherapies that represent the first disease-modifying treatments for Alzheimer's.
Scientists developed mitoDREADD-Gs, a novel tool that restores cognitive function by enhancing mitochondrial activity in mouse models of dementia.
New review reveals promising tau-targeting therapies showing cognitive benefits and slowed brain pathology in Alzheimer's trials.
New precision medicine approach combines genetic risk factors with environmental exposures to predict and prevent dementia.
Research reveals concerning lung complications in MS patients treated with ocrelizumab, raising important safety questions.
Major study finds remote neurologist consultations superior to bedside visits for stroke care quality and guideline adherence.
Research explores how having a meaningful place of belonging supports psychological resilience following traumatic events.
New research reveals how aging brain cells in the amygdala trigger both anxiety and metabolic dysfunction during stress.
PEMFs repair mitochondrial damage and boost brain signaling pathways in stressed neurons, offering new therapeutic hope.
New research reveals how immune cytokines IL-4 and IL-13 directly signal to brain neurons to regulate synapses and cognitive function.
Scientists discover how brain neurons regulate acute lung injury by controlling immune cell activity through the nervous system.